Suhlan Wu

<i>N</i>-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

Md Sayed Ali Sheikh, Zhi‐Ming Shao, Xiao-Su Li et al. · Carcinogenesis · 1995 · 128 citations

Medicine, Oncology, Pharmacology +7

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

Barbara A. Conley, Merrill J. Egorin, Rajeshwari Sridhara et al. · Cancer Chemotherapy and Pharmacology · 1997 · 77 citations

Medicine, Pharmacokinetics, Pharmacology +7

IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells

Naoko Takebe, Xiangfei Cheng, Tamer E. Fandy et al. · Molecular Cancer Therapeutics · 2006 · 77 citations

Medicine, Pharmacology, Pharmacotherapy +17

Functional Characterization of Human Breast Cancer Resistance Protein (BCRP, ABCG2) Expressed in the Oocytes of Xenopus laevis

Takeo Nakanishi, L. Austin Doyle, Bret A. Hassel et al. · Molecular Pharmacology · 2003 · 76 citations

Medicine, Biochemistry, Oncology +15

Pilot Trial of the Safety, Tolerability, and Retinoid Levels of N-(4-hydroxyphenyl) Retinamide in Combination With Tamoxifen in Patients at High Risk for Developing Invasive Breast Cancer

Barbara A. Conley, Joyce O’Shaughnessy, Sheila A. Prindiville et al. · Journal of Clinical Oncology · 2000 · 70 citations

Medicine, Oncology, Pharmacology +12